HT
LXRX icon

HAP Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

HAP Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-143,537
Closed -$872K – 1257
2018
Q4 		$953K Buy
143,537
+102,075
+246% +$827K 0.06% 242
2018
Q3 		$442K Buy
+41,462
New +$475K 0.03% 315
2017
Q4 		– Sell
-151,078
Closed -$1.86M – 1093
2017
Q3 		$1.86M Buy
+151,078
New +$2.23M 0.09% 174

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HAP Trading's LXRX Position: Q1 2019 in Review

HAP Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2019, closing a stake of 143,537 shares — an estimated $872K sold.

HAP Trading first reported a position in LXRX in Q3 2017 and held it in 3 quarters. The position peaked at $1.86M in Q3 2017. 121 funds tracked by Wall St. Rank hold LXRX as of Q1 2019.

  • HAP Trading reported no remaining Lexicon Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • HAP Trading sold 143,537 Lexicon Pharmaceuticals shares in Q1 2019, an estimated $872K.
  • HAP Trading first reported a position in Lexicon Pharmaceuticals in Q3 2017 and held it in 3 quarters.
  • HAP Trading's Lexicon Pharmaceuticals position peaked at $1.86M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2019.

Based on HAP Trading's 13F filing for Q1 2019, filed 10 May 2019.